In this episode, JJ explores the rapidly growing research on psychedelic-assisted therapy and microdosing — and how these natural medicines are helping people heal from PTSD, anxiety, depression, and addiction when traditional methods fall short. She interviews AC Braddock , CEO of Eden Labs.  <a href= "http://edenlabs.com">http://edenlabs.com</a> You’ll learn:✨What recent clinical trials at Johns Hopkins, NYU, and Harvard are revealing about psilocybin and MDMA✨ Why psychedelics are showing success rates of 60–80% for conditions once considered “treatment-resistant”✨ How microdosing differs from full-dose journeys and why it may gently rewire neural pathways for emotional regulation and resilience✨ The historical reasons these substances were made illegal — and why science is finally catching up to their healing potential✨ Practical considerations for safety, integration, and using these tools with reverence rather than recreation Whether you’re curious about microdosing or simply seeking new perspectives on healing trauma and emotional patterns, this episode bridges science, spirituality, and lived experience to illuminate what’s possible when we reconnect the brain, body, and spirit.

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

Ep. 506: Microdosing for PTSD, Anxiety, Depression and Addiction

Spirit, Purpose & Energy

AI Chapters

AI Insights

Reviews